Characterization of a Soluble Suppressor of Human B Cell Immunoglobulin Biosynthesis Produced by a Continuous Human Suppressor T Cell Line
Overview
General Medicine
Affiliations
A human suppressor T cell maintained in long-term culture with conditioned medium containing interleukin 2 elaborates a suppressor factor(s) that specifically inhibits human polyclonal B cell immunoglobulin biosynthesis. This soluble immune suppressor supernate of immunoglobulin production (CTC-SISS-B) shares a number of features with the previously described suppressive mediator elaborated by concanavalin A-activated human peripheral T cells (SISS-B) including: (a) the inhibition by a noncytotoxic mechanism, (b) the suppression of immunoglobulin biosynthesis either through direct action on the B cell or indirect action via the monocyte, (c) the loss of inhibition in the presence of the monosaccharide L-rhamnose, (d) the elaboration by cells irradiated with 500 ro 2,000 rad, and (e) molecular weights of 60,000--90,000. Furthermore, the suppression by this mediator appears to be specific for B cell immunoglobulin production in that CTC-SISS B has no effect on T cell proliferation to mitogens, antigens, an allogeneic cells or on T cell-mediated cytotoxicity. These data indicate that one possible mechanism of suppressor T cell inhibition of human immunoglobulin production is via the generation of a lectinlike suppressor lymphokine that interacts with defined saccharide determinants on the cell surface of either the B cell or monocyte.
Waldmann T, Greene W, SARIN P, Saxinger C, Blayney D, Blattner W J Clin Invest. 1984; 73(6):1711-8.
PMID: 6327770 PMC: 437083. DOI: 10.1172/JCI111379.
Reversal of infectious mononucleosis-associated suppressor T cell activity by D-mannose.
Tosato G, Pike S, Blaese R J Exp Med. 1983; 158(4):1048-60.
PMID: 6225821 PMC: 2187377. DOI: 10.1084/jem.158.4.1048.
Pilarski L, Ruether B, Mant M J Clin Invest. 1985; 75(6):2024-9.
PMID: 2989339 PMC: 425563. DOI: 10.1172/JCI111921.
Use of anti-idiotypic antibodies to identify a receptor for the T-cell I-J determinant.
Zupko K, Waltenbaugh C, Diamond B Proc Natl Acad Sci U S A. 1985; 82(21):7399-403.
PMID: 2932739 PMC: 391352. DOI: 10.1073/pnas.82.21.7399.
Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.
Ebihara T, Koyama S, Fukao K, Osuga T Cancer Immunol Immunother. 1989; 28(3):218-24.
PMID: 2522349 PMC: 11038667. DOI: 10.1007/BF00204992.